Distal Venous Arterialisation of Ischemic Limb
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01211925|
Recruitment Status : Unknown
Verified September 2010 by Clinical Centre of Serbia.
Recruitment status was: Active, not recruiting
First Posted : September 30, 2010
Last Update Posted : September 30, 2010
|Condition or disease||Intervention/treatment||Phase|
|Critical Limb Ischemia||Procedure: distal venous arterialisation Drug: Aspirin||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Distal Venous Arterialisation in the Treatment of Critical Ischemia of Lower Limb|
|Study Start Date :||September 2009|
|Actual Primary Completion Date :||July 2010|
|Estimated Study Completion Date :||July 2011|
|Experimental: critical ischemia||
Procedure: distal venous arterialisation
The investigators perform reverse revascularisation of the ischemic limb with arterial blood supply from patent in flow artery to the superficial dorsal venous arch.
Other Name: Venous arterialisation, arteriovenous reversal
No Intervention: Control
Best medical treatment
100 mg per day continuous
- limb salvage [ Time Frame: 1 year ]The investigators will estimate clinical improvement in patients with critical limb ischemia underwent of distal venous arterialisation. Comparative group consist patients treated with antiplatelet drugs.
- lactate level in the blood of deep venous system [ Time Frame: 1 year ]The investigators measure metabolic changes in the patients after distal venous arterialisation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01211925
|Clinical Center of Serbia|
|Belgrade, Serbia, 11000|
|Principal Investigator:||Predrag Vl Djoric, MD||Clinical Center of Serbia in Belgrade, Clinic for Vascular and Endovascular Surgery|